- Antigen-presenting cells and inflammatory response
- Pharmacogenomics
- Physiology of Inflammatory processes
- Experimental Oncology
- Genetics of Lymphoid Malignancies
- Hematological genetics
- Molecular Genetics of Hemophilia
- Haemostasis and thrombosis
- Immunology of Respiratory Diseases
- Experimental immunology
- Innate immunity
- Onco-immunology
- Mutagenesis
- Pathogenesis and inmunology of infectious processes
- Pathogenesis of viral infections
- Trombosis Experimental e Inmunobiología de la Inflamación
PATHOGENESIS OF VIRAL INFECTION
The focus of our laboratory is the study of human viral infections and includes the study of the infectious agent, its detection and diagnosis and the processes in the host. We also investigate different viral, immunological or genetic factors that may be associated with the clinical presentation of the disease. We demonstrated the existence of replication of Hepatitis C virus (HCV) in mononuclear cell cultures and cell lines and studied the genotypes associated with this site, highlighting its importance as a viral reservoir. We evaluated different clinical, virological, immunological and genetic aspects that could have an impact on the progression of human immunodeficiency virus and the hepatitis C virus coinfection (HIV-HCV). We have conducted studies evaluating the persistence of humoral and cellular immune memory in vaccinated individuals. Currently, our research projects are mainly focused on studies of the dengue virus and SARS-CoV-2. We maintain collaborations with different institutions and laboratories that include the CEBAC laboratory of Posadas, Misiones, with the virology laboratory of the Facultad de Farmacia y Bioquímica (UBA) and the Infectious Diseases Laboratory of the National Institutes of Health of the United States (NIH)). We develop and apply cell culture, molecular biology and immunology techniques to study different aspects of the pathogenesis of different viral infections.
Chair: Patricia Baré, PhD – CONICET Independent researcher.
Email: patobare@gmail.com
- GOLDSTEIN de FINK, Susana. CONICET Independent researcher.
- ELIZALDE DE BRACCO, María Marta. CONICET Superior researcher.
- ESPINDOLA, Sonia. CONICET Assistant researcher.
- ALOISI, Natalia. IIHEMA
- BADANO, María Noel. IIHEMA
- PERESON, Matías Javier. PhD student – CONICET.
- CARBALLO Graciela – Molecular biology magister student
HEPATITIS A virus INFECTION Study of cellular immunity in individuals vaccinated against hepatitis A with a single dose DENGUE virus INFECTION
1-Diagnosis of acute dengue infection during the 2016 outbreak. Frequency of secondary infections in the region.
2-Polymorphisms and levels of cytokines in plasma. Association with the clinical presentation in dengue infection.
3-Development of the dengue infection system in peripheral mononuclear cells.
INFECTION by SARS-CoV-2
1-Randomized Phase II Clinical Study, of Parallel Groups, controlled with Placebo, to evaluate the Efficacy and Safety of Nitazoxanide (NTX), in Patients with Mild Symptoms associated with the SARS-CoV2 virus (COVID19).
2-Persistence of immunological memory against SARS-CoV-2 in vaccinated individuals 3-Cytokine analysis in SARS-CoV-2 infection
- Badano MN, Duarte A, Salamone G, Sabbione F, Pereson M, Chuit R, Baré P. Prevalence of salivary anti-SARS-CoV-2 IgG antibodies in vaccinated children. Immunology. 2023 May 15. doi: 10.1111/imm.13656. Epub ahead of print. PMID: 37188378.
- Badano MN, Pereson MJ, Sabbione F, Keitelman I, Aloisi N, Chuit R, de Bracco MME, Fink S, Baré P. SARS-CoV-2 Breakthrough Infections after Third Doses Boost IgG Specific Salivary and Blood Antibodies. Vaccines (Basel). 2023 Feb 24;11(3):534. doi: 10.3390/vaccines11030534. PMID: 36992118; PMCID: PMC10054801
- Erra L, Uriarte I, Colado A, Paolini MV, Seminario G, Fernández JB, Tau L, Bernatowiez J, Moreira I, Vishnopolska S, Rumbo M, Cassarino C, Vijoditz G, López AL, Curciarello R, Rodríguez D, Rizzo G, Ferreyra M, Ferreyra Mufarregue LR, Badano MN, Pérez Millán MI, Quiroga MF, Baré P, Ibañez I, Pozner R, Borge M, Docena G, Bezrodnik L, Almejun MB. COVID-19 Vaccination Responses with Different Vaccine Platforms in Patients with Inborn Errors of Immunity. J Clin Immunol. 2022 Oct 17:1–15. doi: 10.1007/s10875-022-01382-7. Epub ahead of print. PMID: 36251205; PMCID: PMC9574808.
- Pereson MJ, Amaya L, Neukam K, Bare P, Echegoyen N, Noel Badano M, Lucero A, Martelli A, Garcia GH, Videla C, Martínez AP, Di Lello FA. Heterologous Gam-COVID-Vac (sputnik V) / mRNA-1273 (Moderna) vaccination induces a stronger humoral response than homologous sputnik V in a real-world data analysis. Clin Microbiol Infect. 2022 May 17: S1198-743X(22)00265-8. doi: 10.1016/j.cmi.2022.05.009. Epub ahead of print. PMID: 35595128; PMCID: PMC9112602.
- Pereson MJ, Badano MN, Aloisi N, Chuit R, E de Bracco MM, Bare P. TNF-α Levels in Respiratory Samples Are Associated with SARS-CoV-2 Infection. Microbiol Spectr. 2022 Feb 23;10(1):e0141121. doi: 10.1128/spectrum.01411-21. Epub 2022 Feb 9. PMID: 35138148; PMCID: PMC8826736.
- Badano MN, Sabbione F, Keitelman I, Pereson M, Aloisi N, Colado A, Ramos MV, Ortiz Wilczyñski JM, Pozner RG, Castillo L, Wigdorovitz G, E de Bracco MM, Fink S, Chuit R, Baré P. Humoral response to the BBIBP-CorV vaccine over time in healthcare workers with or without exposure to SARS-CoV-2. Mol Immunol. 2022 Mar;143:94-99. doi: 10.1016/j.molimm.2022.01.009. Epub 2022 Jan 17. PMID: 35091231; PMCID: PMC8761547.
- Flichman DM, Pereson MJ, Baré P, Espindola SL, Carballo GM, Albrecht A, Agote F, Alter A, Bartoli S, Blanco S, Blejer J, Borda M, Bouzon N, Carrizo LH, Etcheverry L, Fernandez R, Reyes MIF, Gallego S, Hahn R, Luna SG, Marranzino G, Romanazzi JS, Rossi A, Troffe A, Lin CC, Martínez AP, García G, DI Lello FA. Epidemiology of Dengue in Argentina: Antibodies seroprevalence in blood donors and circulating serotypes. J Clin Virol. 2022 Jan 5;147:105078. doi: 10.1016/j.jcv.2022.105078. Epub ahead of print. PMID: 34999567.
- Villamil FG, Massenzio NE, Baré PC, Cocco PA, Cairo FM, Picchio GR. Twenty-year follow-up of an outbreak of hepatitis C in a small rural town of Argentina: The O’Brien Project. Ann Hepatol. 2022 Jan;27 Suppl 1:100577. doi: 10.1016/j.aohep.2021.100577. Epub 2021 Nov 3. PMID: 34740846.
- Urueña A, Badano MN, Baré P, González J, Vicentín R, Calli R, Cañero-Velasco MC, Fink S, Vizzotti C. Humoral and cellular immune memory response 12 years following single dose vaccination against hepatitis A in Argentinian children. Vaccine. 2022 Jan 3;40(1):114-121. doi: 10.1016/j.vaccine.2021.11.037. Epub 2021 Nov 24. PMID: 34838323.
- Pereson MJ, Flichman DM, Martínez AP, Baré P, Garcia GH, Di Lello FA. Evolutionary analysis of SARS-CoV-2 spike protein for its different clades. J Med Virol. 2021 May;93(5):3000-3006.
- Monzani MC, Badano MN, Aloisi N, Gualtieri A, Corti M, Parodi C, de Tezanos Pinto M, Neme D, Primiani L, E de Bracco MM, Chuit R, Baré P. Controlled HIV-HCV Viremia and Immune-Reconstitution are Associated with Slow Progression of Liver Disease in Co-infected Hemophilic Patients After 30 Years of Follow-Up. Japanese Journal of Gastroenterol and Hepatology, 2020; V4(4):1-7.
- Badano MN, Parodi C, Aloisi N, Corti M, Elizalde de Bracco MM, Baré P. Influence of Hepatitis C virus coinfection on immune reconstitution in HIV subjects. Med Microbiol Immunol. 2019; 208(6):747-756.
- Piñero F, Vazquez M, Baré P, Rohr C, Mendizbal M, Sciara M, Alonso C, Fay F, Silva M. A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma. Ann Hepatol. 2019 May -Jun;18(3):480-487.
- Culasso ACA, Monzani MC, Baré P, Campos RH. Evolutionary dynamics of Hepatitis C virus in a chronic HIV co-infected patient and its correlation with the immune status. Infect Genet Evol. 2018 May 4; 63: 30-38.
- Baré P, Parodi C, Malbrán A, E de Bracco MMarta. Progressive reduction of circulating b lymphocytes in patients with X-linked lymphoproliferative disease (XLP). Br J Haematol. 2017; 177(4):648-650.
- Wang RY, Baré P, De Giorgi V, Matsuura K, Salam KA, Grandinetti T, Schechterly C, Alter HJ. Preferential Association of Hepatitis C Virus with CD19+ B Cells Is mediated by Complement System. Hepatology. 2016; 64(6):1900-1910
- Fujiwara K, Allison RD, Wang RY, Bare P, Matsuura K, Schechterly C, Murthy K, Marincola FM, Alter HJ. Investigation of residual hepatitis C virus in presumed recovered subjects. Hepatology. 2013; 57(2):483-91